Early lens aging is accelerated in subjects with a high risk of ischemic heart disease: An epidemiologic study

BMC Ophthalmology

Volumn 6, Issue , 2006, Pages

  Kessel, Line ^a   Jørgensen, Torben ^b   Glümer, Charlotte ^b,c   Larsen, Michael ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGING; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; FLUOROMETRY; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LENS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; SMOKING; DIABETES MELLITUS; FLUORESCENCE; FLUOROPHOTOMETRY; METABOLISM; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR;

ADULT; DIABETES COMPLICATIONS; FEMALE; FLUORESCENCE; FLUOROPHOTOMETRY; HUMANS; LENS, CRYSTALLINE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 33646540761     PISSN: 14712415     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-6-16     Document Type: Article

References (36)

1. Sans S, Kesteloot H, Kromhout D: The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997, 18:1231-1248.
2. Bhargava A: A longitudinal analysis of the risk factors for diabetes and coronary heart disease in the Framingham Offspring Study. Popul Health Metr 2003, 1:.
3. Hiller R, Sperduto RD, Podgor MJ, Wilson PW, Ferris FLIII, Colton T, D'Agostino RB, Roseman MJ, Stockman ME, Milton RC: Cigarette smoking and the risk of development of lens opacities. The Framingham studies. Arch Ophthalmol 1997, 115:1113-1118.
4. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 1995, 38:86-96.
5. Hu FB, Hankinson SE, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC: Prospective study of cataract extraction and risk of coronary heart disease in women. Am J Epidemiol 2001, 153:875-881.
6. Delcourt C, Cristol JP, Tessier F, Leger CL, Michel F, PApoz L, group TPOLA: Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Am J Epidemiol 2000, 151:497-504 [http://PM:0011004323].
7. Spector A: Review: Oxidative stress and disease. J Ocul Pharmacol Ther 2000, 16:193-201.
8. Chylack LTJ: Mechanisms of senile cataract formation. Ophthalmology 1984, 91:596-602.
9. Arnarsson A, Jonasson F, Sasaki H, Ono M, Jonsson V, Kojima M, Katoh N, Sasaki K: Risk factors for nuclear lens opacification: the Reykjavik Eye Study. Dev Ophthalmol 2002, 35:12-20.
10. Hirvelä H, Luukinen H, Laatikainen L: Prevalence and risk factors of lens opacities in the elderly in Finland. A population-based study. Ophthalmology 1995, 102:108-117.
11. West S, Munoz B, Emmett EA, Taylor HR: Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol 1989, 107:1166-1169.
12. Leske MC, Chylack LTJ, Wu SY: The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991, 109:244-251.
13. Ulrich P, Cerami A: Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001, 56:1-21.
14. Nicholl ID, Bucala R: Advanced glycation endproducts and cigarette smoking. Cell Mol Biol (Noisy -le-grand) 1998, 44:1025-1033.
15. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR: The advanced glycation end product, Nepsilon-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996, 271:9982-9986.
16. Makita Z, Yanagisawa K, Kuwajima S, Bucala R, Vlassara H, Koike T: The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis. Nephrol Dial Transplant 1996, 11 Suppl 5:31-33.
17. Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P, Cerami A, Levy BI: Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A 1998, 95:4630-4634.
18. Das BK, Sun TX, Akhtar NJ, Chylack LTJ, Liang JJ: Fluorescence and immunochemical studies of advanced glycation-related lens pigments. Invest Ophthalmol Vis Sci 1998, 39:2058-2066.
19. Lyons TJ, Silvestri G, Dunn JA, Dyer DG, Baynes JW: Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes 1991, 40:1010-1015.
20. Abiko T, Abiko A, Ishiko S, Takeda M, Horiuchi S, Yoshida A: Relationship between autofluorescence and advanced glycation end products in diabetic lenses. Exp Eye Res 1999, 68:361-366.
21. Thomsen TF, Davidsen M, Jørgensen T, Ibsen H, Jensen G, Borch-Johnsen K: A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk 2001, 8:291-297.
22. Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ: Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 2001, 46:59-80.
23. Schwartz RS, Bayes-Genis A, Lesser JR, Sangiorgi M, Henry TD, Conover CA: Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers. J Interv Cardiol 2003, 16:231-242.
24. Pahor M, Elam MB, Garrison RJ, Kritchevsky SB, Applegate WB: Emerging noninvasive biochemical measures to predict cardiovascular risk. Arch Intern Med 1999, 159:237-245.
25. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C: A randomised non-pharmacological intervention study for prevention of ischemic heart disease. Baseline results. Inter99 (1). Eur J Cardiovasc Prevention Rehab 2003, 10:377-386.
26. Siik S, Airaksinen PJ, Tuulonen A, Nieminen H: Autofluorescence in cataractous human lens and its relationship to light scatter. Acta Ophthalmol (Copenh) 1993, 71:388-392.
27. Kessel L, Hougaard JL, Sander B, Kyvik KO, Sørensen TI, Larsen M: Lens ageing as an indicator of tissue damage associated with smoking and non-enzymatic glycation - a twin study. Diabetologia 2002, 45:1457-1462.
28. Chylack LTJ, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY: The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993, 111:831-836.
29. Siik S, Chylack LTJ, Friend J, Wolfe J, Teikari J, Nieminen H, Airaksinen PJ: Lens autofluorescence and light scatter in relation to the lens opacities classification system, LOCS III. Acta Ophthalmol Scand 1999, 77:509-514.
30. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. In WHO/NCD/NCS/99 2 Geneva, WHO. Department of noncommunicable disease surveillance; 1999.
31. Alberti KG: The clinical implications of impaired glucose tolerance. Diabet Med 1996, 13:927-937.
32. Monnier VM, Kohn RR, Cerami A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A 1984, 81:583-587.
33. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al Abed Y, Vlassara H, Bucala R, Cerami A: Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A 1997, 94:13915-13920.
34. Lusis AJ: Atherosclerosis. Nature 2000, 407:233-241.
35. Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ: The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 1996, 39:946-951.
36. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991, 87:432-438.